“We may see two or four multinational, chemical companies emerging out of India”
Kotak Mahindra's Pankaj Tibrewal on the structural shift in specialty chemicals and why portfolio construction should trump stock picking
N Mahalakshmi - March 01, 2021
Jingoism buried, IPO done, stock price up 50%. What next for Gland Pharma?
Its IPO was talk of the town, but investors gave it a miss. Now, the company is having the last laugh
V Keshavdev - December 10, 2020
"RATING AGENCIES HAVE NO LEGAL LIABILITY, BUT THIS DOWNGRADE CAN ACT AS A WARNING"
In an interview with Outlook Business, CII president and Kotak Mahindra Bank MD Uday Kotak discusses the need of the hour
N Mahalakshmi - June 09, 2020
In cash we trust
Paritosh Kashyap sells Kotak Mahindra Bank shares worth Rs.151 million
April 25, 2020
The complete package
With Vinay Pathak as ‘Subbu’, Kotak Mahindra highlights the benefits of their ‘complete’ life insurance
Shruti Venkatesh - January 07, 2020
The Outperformers (71-80)
These companies have been ranked based on their stock's excess return over the Sensex for a five-year period
September 03, 2019
The Prudent Banker
Amid slow growth and poor governance in financial services, Kotak Mahindra Bank continues to steer ahead with a clear growth strategy
V Keshavdev - July 10, 2019
“We are in the midst of Swachh Bharat in the financial sector”
Kotak Mahindra Bank MD & CEO Uday Kotak on the financial sector and the disruption in store
N Mahalakshmi - July 11, 2019
Shifting Sands
Playtime is up for asset management companies, who have been designing imaginative schemes, as Sebi steps in with new regulations. Now it is time for fund managers to colour within the lines
Kripa Mahalingam - February 07, 2019
Mr. Dependable
By choosing to focus on quality over valuation, Shreyash Devalkar has consistently managed to outperform the market
Prathamesh Mulye - February 12, 2019
